Navigation Links
Small bowel blood flow in healthy subjects receiving low-dose aspirin
Date:1/25/2011

Low-dose acetylsalicylic acid (ASA) has been widely used for prevention of cardiovascular and cerebrovascular events. Several studies have shown that mucosal breaks caused by taking low-dose ASA occurred not only in the upper gastrointestinal tract but also in the lower gastrointestinal tract. However the cause of small bowel injury is not clear. One of the mechanisms of drug-induced small bowel damage is decrease in blood flow.

A research article to be published on January 14, 2011 in the World Journal of Gastroenterology addresses this question. The authors investigated the relationship between low-dose ASA-induced small bowel mucosal damage and small bowel blood flow, and also evaluated the preventive effect of rebamipide against small bowel damage and the effect of rebamipide on blood flow.

The results indicated that low-dose ASA-induced decrease in small bowel blood flow is correlated with small-bowel mucosal injury. Rebamipide does not decrease small bowel blood flow.

This study may represent a future strategy for therapeutic intervention in the treatment of patients with low-dose aspirin-induced small bowel mucosal damage.


'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Heavy Smoking Linked to Small Increase in Breast Cancer Risk
2. Preparing Small Doses of Medication From Syringes Called Risky
3. Small Spreads of Breast Cancer May Not Affect Survival
4. Small molecules may prevent ebola infection
5. MIT neuroscientists explain Proustian effect of small details attached to big memories
6. Deadliest Cancer Getting Smaller Chunk of Research Dollars
7. Small molecule may disarm enemy of cancer-fighting p53
8. Small assist device used in emergency case as twin, heart booster pumps for first time in US
9. Unexpectedly small effects of mutations in bacteria bring new perspectives
10. UCI non-small cell lung cancer study highlights advances in targeted drug therapy
11. Small particles show big promise in beating unpleasant odors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... Healthcare Associates of McKinney ... at Craig Ranch building at 8080 State Highway 121, Suite 210, McKinney, Texas 75070. ... access to Highway 121. , As the practice has grown, the need for more ...
(Date:2/24/2017)... , ... February 24, 2017 , ... The International Association ... annual “Imagine Me Beyond What You See” body image mannequin art competition. Selected from ... be showcased and the winner revealed at the 31st annual iaedp Symposium, March 22 ...
(Date:2/24/2017)... ... 2017 , ... Castle Farms, the celebrated Northern Michigan ... the winning couple announced on Feb. 14, 2017, on Facebook. The free wedding ... A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring and Other ...
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... approved content provider for the National Institute for Health and Care Excellence ... care-related organizations in the National Health Service (NHS) to search, order and purchase ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... CHEYENNE, Wyoming , Feb. 24, 2017  Xynomic ... company, today announced that it has acquired exclusive ... a potentially best-in-class innovative HDAC inhibitor targeting hematological ... total of 14 Phase 1 and 2 clinical ... Asia have already been completed, ...
(Date:2/23/2017)... -- Genesis Healthcare Services has merged with Hospice Cloud, a ... Bill Monast , President and CEO of Hospice Cloud ... , executives with Home Health Depot, Inc., the parent ... This acquisition helps Hospice Cloud maintain its position as ... equipment (DME) solutions for the hospice industry. Nathan ...
(Date:2/23/2017)... Nevro Corp. (NYSE: NVRO), a global medical device ... of chronic pain, today reported financial results for the three ... 2016 Accomplishment & Highlights: Achieved revenue ... of 228% as reported, over the prior year ... 612% over the prior year International revenue ...
Breaking Medicine Technology: